MedTrace Logo

Late Clinical Events Associated With COVID-19 Infection

NCT04591613 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2022-05-10

No results posted yet for this study

Summary

Several publications document the occurrence of symptoms that persist or occur late.

The identification of the observed clinical manifestations and their clinical and paraclinical description are essential to better understand the natural evolution of COVID-19, to clarify the pathophysiological mechanism of these possible late manifestations, and to identify potential management options for patients.

Since this type of event is infrequent, a large-scale national multicenter cohort study focusing on symptomatic patients is needed.

Conditions

  • Covid19

Interventions

OTHER

Questionnaire

Quality of life and chronic disease impact scales will be completed at inclusion and follow-up visits.

OTHER

Biocollection

Total serum, plasma samples will be collected

OTHER

Follow-up visit

All patients will make an inclusion visit (IV), then a clinical follow-up will be organized for the study at M4, M6, M12 from the day of the onset of the 1st symptoms of COVID.

Sponsors & Collaborators

  • Tourcoing Hospital

    lead OTHER

Principal Investigators

  • Olivier ROBINEAU, MD PhD · CH TOURCOING

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2024-12-31
Completion
2025-08-31

Countries

  • France
  • French Guiana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04591613 on ClinicalTrials.gov